Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.08 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |